Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness

被引:189
作者
Ouimette, PC
Finney, JW
Moos, RH
机构
[1] VET AFFAIRS PALO ALTO HLTH CARE SYST, MENLO PK DIV 152, HSR & D, CTR HLTH CARE EVALUAT, MENLO PK, CA 94025 USA
[2] STANFORD UNIV, MED CTR, STANFORD, CA 94305 USA
关键词
D O I
10.1037/0022-006X.65.2.230
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The comparative effectiveness of 12-step and cognitive-behavioral (C-B) models of substance abuse treatment was examined among 3,018 patients from 15 programs at U.S. Department of Veterans Affairs Medical Centers. Across program types, participants showed significant improvements in functioning from treatment admission to a 1-year follow-up. Although 12-step patients were somewhat more likely to be abstinent at the 1-year follow-up, 12-step, C-B, and combined 12-Step-C-B treatment programs were equally effective in reducing substance use and improving most other areas of functioning. The finding of equal effectiveness was consistent over several treatment subgroups: Patients attending the ''purest'' 12-step and C-B treatment programs, and patients who had received the ''full dose'' of treatment. Also, patients with only substance abuse diagnoses, those with concomitant psychiatric diagnoses, and patients who were mandated to treatment showed similar improvement at the 1-year follow-up, regardless of type of treatment received. These data provide important new evidence supporting the effectiveness of 12-step treatment.
引用
收藏
页码:230 / 240
页数:11
相关论文
共 53 条
[1]  
[Anonymous], 1989, Drug abuse treatment: A national study of effectiveness
[2]   VERBAL REPORT METHODS IN CLINICAL RESEARCH ON ALCOHOLISM - RESPONSE BIAS AND ITS MINIMIZATION [J].
BABOR, TF ;
STEPHENS, RS ;
MARLATT, GA .
JOURNAL OF STUDIES ON ALCOHOL, 1987, 48 (05) :410-424
[3]   RISK-FACTORS FOR DEPRESSIVE SYMPTOMATOLOGY IN A DRUG USING POPULATION [J].
BUCKNER, JC ;
MANDELL, W .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1990, 80 (05) :580-585
[4]  
BUXTON ME, 1987, J PSYCHOACTIVE DRUGS, V21, P221
[5]   Methodological issues and problems in the assessment of substance use [J].
Carroll, KM .
PSYCHOLOGICAL ASSESSMENT, 1995, 7 (03) :349-358
[6]  
COHEN J, 1987, STATISTICAL POWER BE
[7]   CRITERION INTERVALS FOR PRETREATMENT DRINKING MEASURES IN TREATMENT EVALUATION [J].
COOPER, AM ;
SOBELL, MB ;
MAISTO, SA ;
SOBELL, LC .
JOURNAL OF STUDIES ON ALCOHOL, 1980, 41 (11) :1186-1195
[8]   THE BRIEF SYMPTOM INVENTORY - AN INTRODUCTORY REPORT [J].
DEROGATIS, LR ;
MELISARATOS, N .
PSYCHOLOGICAL MEDICINE, 1983, 13 (03) :595-605
[9]  
DiClemente C C, 1990, J Subst Abuse, V2, P217, DOI 10.1016/S0899-3289(05)80057-4
[10]  
ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971